Gene · 808
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical detection, diagnosis and treatment of morphological abnormalities of sperm flagella: A review of literature. | Front Genet | 2022 | 36425067 | PubTator, text mining | PubMed |
| Structural insights into caspase ADPR deacylization catalyzed by a bacterial effector and host calmodulin. | Mol Cell | 2022 | 36423631 | Swiss-Prot, curated | PubMed |
| AKAP9-Related Channelopathy: Novel Pathogenic Variant and Review of the Literature. | Genes (Basel) | 2022 | 36421840 | PubTator, text mining | PubMed |
| Calmodulin-dependent protein kinase II activation promotes kidney mesangial expansion in streptozotocin-induced diabetic mice. | Heliyon | 2022 | 36411910 | PubTator, text mining | PubMed |
| Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer. | Front Immunol | 2022 | 36405725 | PubTator, text mining | PubMed |
| CaMKII regulates neuromuscular activity and survival of the human blood fluke Schistosoma mansoni. | Sci Rep | 2022 | 36400915 | PubTator, text mining | PubMed |
| A systematic review and network meta-analysis of first-line immune checkpoint inhibitor combination therapies in patients with advanced non-squamous non-small cell lung cancer. | Front Immunol | 2022 | 36389713 | PubTator, text mining | PubMed |
| Author Response: Inhaled CO2 Concentration While Wearing Face Masks: A Pilot Study Using Capnography. | Environ Health Insights | 2022 | 36389652 | PubTator, text mining | PubMed |
| The Food and Drug Administration-approved antipsychotic drug trifluoperazine, a calmodulin antagonist, inhibits viral replication through PERK-eIF2α axis. | Front Microbiol | 2022 | 36386620 | PubTator, text mining | PubMed |
| New insights into the characteristics of DRAK2 and its role in apoptosis: From molecular mechanisms to clinically applied potential. | Front Pharmacol | 2022 | 36386181 | PubTator, text mining | PubMed |
| Molecular Dynamics Simulations of the Cardiac Ryanodine Receptor Type 2 (RyR2) Gating Mechanism. | J Phys Chem B | 2022 | 36384028 | PubTator, text mining | PubMed |
| Otomycosis caused by the cryptic and emerging species Aspergillus sydowii: two case reports. | Future Microbiol | 2022 | 36382573 | PubTator, text mining | PubMed |
| Genetics of congenital arrhythmia syndromes: the challenge of variant interpretation. | Curr Opin Genet Dev | 2022 | 36368182 | PubTator, text mining | PubMed |
| Tocotrienol-Rich Fraction and Levodopa Regulate Proteins Involved in Parkinson's Disease-Associated Pathways in Differentiated Neuroblastoma Cells: Insights from Quantitative Proteomic Analysis. | Nutrients | 2022 | 36364894 | PubTator, text mining | PubMed |
| Co-Sensitization Effects of Indoline and Carbazole Dyes in Solar Cells and Their Neutral-Anion Equilibrium in Solution. | Materials (Basel) | 2022 | 36363315 | PubTator, text mining | PubMed |
| Skeletal Muscle Regeneration in Cardiotoxin-Induced Muscle Injury Models. | Int J Mol Sci | 2022 | 36362166 | PubTator, text mining | PubMed |
| Alzheimer's Disease: From Immune Homeostasis to Neuroinflammatory Condition. | Int J Mol Sci | 2022 | 36361799 | PubTator, text mining | PubMed |
| The HSF1-CPT1a Pathway Is Differentially Regulated in NAFLD Progression. | Cells | 2022 | 36359900 | PubTator, text mining | PubMed |
| Cross-Talk and Subset Control of Microglia and Associated Myeloid Cells in Neurological Disorders. | Cells | 2022 | 36359758 | PubTator, text mining | PubMed |
| Genetically-encoded BRET probes shed light on ligand bias-induced variable ion selectivity in TRPV1 and P2X5/7. | Proc Natl Acad Sci U S A | 2022 | 36343259 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/808/papers?page=33